Nordion Inc Com (NYSE:NDZ)

CAPS Rating: 3 out of 5

Global health and life sciences company that provides enabling technologies, products, and services to improve the delivery of healthcare worldwide. Primary focuses are drug development and disease diagnosis.

Recs

1
Player Avatar racoveanul (80.21) Submitted: 9/28/2007 1:37:48 PM : Underperform Start Price: $21.12 NDZ Score: +41.10

Conan Holder < 1.5 (bankruptcy risk > 75%), Altman for private companies Z score < 1.23. This company is in bad shape; other companies with valuation problems: BOW, CMS, TRY.B, LUK, LPX, SNSTA, TECUA, XRIT, CAR, VOD, GDP, MDZ, MCF, EPL, VMED, MIC, LINE, BKD ,AAV, EROC.

Featured Broker Partners


Advertisement